| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020040825 |
| P356 | DOI | 10.1038/NM952 |
| P698 | PubMed publication ID | 14566335 |
| P5875 | ResearchGate publication ID | 9045327 |
| P2093 | author name string | André Lieber | |
| Dmitry M Shayakhmetov | |||
| Anuj Gaggar | |||
| P2860 | cites work | Virus-Receptor Interaction in an Adenovirus System | Q37124281 |
| Targeting and hematopoietic suppression of human CD34+ cells by measles virus | Q39683823 | ||
| There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses | Q39699178 | ||
| The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses | Q39732535 | ||
| Adenovirus type 11 uses CD46 as a cellular receptor | Q39864028 | ||
| Genetic variability of adenoviruses | Q40124294 | ||
| Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae | Q40917425 | ||
| Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. | Q43567134 | ||
| CD46 is a cellular receptor for human herpesvirus 6. | Q44613357 | ||
| Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome | Q64380942 | ||
| HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses | Q24312224 | ||
| The human CD46 molecule is a receptor for measles virus (Edmonston strain) | Q24317745 | ||
| Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels | Q27860531 | ||
| Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
| Membrane cofactor protein (MCP; CD46) expression in transgenic mice | Q28367582 | ||
| Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease | Q30830095 | ||
| A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37. | Q31807075 | ||
| Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector | Q33799667 | ||
| Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions | Q33800666 | ||
| Adenoviruses in the immunocompromised host | Q35231548 | ||
| Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. | Q36811928 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 1408-1412 | |
| P577 | publication date | 2003-10-19 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | CD46 is a cellular receptor for group B adenoviruses | |
| P478 | volume | 9 |
| Q64377866 | 1. Alternative splicing of viral receptors: A review of the diverse morphologies and physiologies of adenoviral receptors |
| Q39655243 | 5/35 Fiber-Modified Conditionally Replicative Adenovirus Armed with p53 Shows Increased Tumor-Suppressing Capacity to Breast Cancer Cells |
| Q40182476 | A CD46-binding chimpanzee adenovirus vector as a vaccine carrier. |
| Q24530140 | A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression |
| Q37647461 | A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1. |
| Q40223632 | A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. |
| Q40090311 | A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression |
| Q30959165 | A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy |
| Q38954393 | A reduction in the human adenovirus virion size through use of a shortened fibre protein does not enhance muscle transduction following systemic or localised delivery in mice. |
| Q40565608 | A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. |
| Q58795206 | AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6 |
| Q36210847 | Activation of antigen-presenting cells by DNA delivery vectors |
| Q38713433 | Active and separate secretion of fiber and penton base during the early phase of Ad2 or Ad5 infection |
| Q34616438 | Acute bacterial meningitis in infants and children |
| Q37945217 | Adenoviral producer cells |
| Q33565630 | Adenoviral vector immunity: its implications and circumvention strategies |
| Q38814885 | Adenoviral vector-based strategies against infectious disease and cancer |
| Q34977219 | Adenovirus |
| Q39679145 | Adenovirus 11p downregulates CD46 early in infection |
| Q39722004 | Adenovirus 5 and chimeric adenovirus 5/F35 employ distinct B-lymphocyte intracellular trafficking routes that are independent of their cognate cell surface receptor |
| Q27469833 | Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity |
| Q36003090 | Adenovirus as an emerging pathogen in immunocompromised patients |
| Q38989106 | Adenovirus assembly is impaired by BMI1-related histone deacetylase activity |
| Q40437659 | Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12. |
| Q92697845 | Adenovirus early region 3 RIDα protein limits NFκB signaling through stress-activated EGF receptors |
| Q64096999 | Adenovirus flow in host cell networks |
| Q24293503 | Adenovirus gene transfer to amelogenesis imperfecta ameloblast-like cells |
| Q36746433 | Adenovirus infection after allogeneic stem cell transplantation |
| Q52375195 | Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. |
| Q64374953 | Adenovirus interactions with CD46 on transgenic mouse erythrocytes |
| Q28084476 | Adenovirus membrane penetration: Tickling the tail of a sleeping dragon |
| Q33984709 | Adenovirus protein VI mediates membrane disruption following capsid disassembly. |
| Q33984229 | Adenovirus receptors |
| Q33994011 | Adenovirus receptors and their implications in gene delivery |
| Q39065475 | Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapy |
| Q36276518 | Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys |
| Q50895162 | Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. |
| Q45856784 | Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice |
| Q38053484 | Adenovirus signalling in entry |
| Q27643524 | Adenovirus type 11 binding alters the conformation of its receptor CD46 |
| Q40572766 | Adenovirus type 7 induces interleukin-8 in a lung slice model and requires activation of Erk. |
| Q34938294 | Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation |
| Q43541906 | Adenovirus types 11p and 35 attach to and infect primary lymphocytes and monocytes, but hexon expression in T-cells requires prior activation |
| Q39595299 | Adenovirus vector-mediated assay system for hepatitis C virus replication |
| Q33845053 | Adenovirus vectors targeting distinct cell types in the retina |
| Q34178208 | Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae |
| Q38187126 | Adenovirus-triggered innate signalling pathways |
| Q45871162 | Adenoviruses 16 and CV23 efficiently transduce human low-passage brain tumor and cancer stem cells |
| Q34353523 | Adenoviruses as vaccine vectors |
| Q40213253 | Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells |
| Q36468656 | Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism |
| Q37859842 | Advances and future challenges in adenoviral vector pharmacology and targeting |
| Q33397385 | Alternate serotype adenovector provides long-term therapeutic gene expression in the eye. |
| Q27652785 | An Arginine Switch in the Species B Adenovirus Knob Determines High-Affinity Engagement of Cellular Receptor CD46 |
| Q39657553 | An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations |
| Q37848821 | An adenovirus traffic update: from receptor engagement to the nuclear pore |
| Q37945220 | An update on canine adenovirus type 2 and its vectors |
| Q40815226 | Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors |
| Q36009025 | Analysis of human adenovirus type 19 associated with epidemic keratoconjunctivitis and its reclassification as adenovirus type 64. |
| Q35183935 | Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling |
| Q38613979 | Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery. |
| Q43655746 | Attenuation of CD4+ T-cell function by human adenovirus type 35 is mediated by the knob protein |
| Q35689715 | Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection |
| Q34194285 | Biodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice |
| Q45877055 | Bioluminescence imaging reveals a significant role for complement in liver transduction following intravenous delivery of adenovirus |
| Q47232092 | Blood Coagulation Factor X Exerts Differential Effects on Adenovirus Entry into Human Lymphocytes |
| Q37346346 | Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry |
| Q40424773 | Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3. |
| Q36845102 | CD46 Contributes to the severity of group A streptococcal infection |
| Q37864688 | CD46 in innate and adaptive immunity: an update. |
| Q39612847 | CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7. |
| Q37832444 | CD46 plasticity and its inflammatory bias in multiple sclerosis |
| Q42613180 | CD46 transgenic mouse model of necrotizing fasciitis caused by Streptococcus pyogenes infection |
| Q42016952 | CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines |
| Q35831659 | CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function |
| Q28744246 | Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction |
| Q30525107 | Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model |
| Q34643252 | Chapter two--Adenovirus strategies for tissue-specific targeting |
| Q37442235 | Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents |
| Q39974612 | Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo |
| Q33821284 | Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells |
| Q34612406 | Chimeric adenovirus 5/35 vector containing the clade C HIV gag gene induces a cross-reactive immune response against HIV. |
| Q45401922 | Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys |
| Q36510436 | Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2. |
| Q39462577 | Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells |
| Q41610747 | Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes. |
| Q39892766 | Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells |
| Q40440806 | Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer |
| Q39916263 | Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer |
| Q45117334 | Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells |
| Q36559772 | Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors |
| Q36674446 | Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization |
| Q34045541 | Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications |
| Q35857420 | Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D |
| Q38297861 | Comparison of adenoviruses from species B, C, E, and F after intravenous delivery |
| Q34625495 | Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment |
| Q33804431 | Complement Evasion Strategies of Viruses: An Overview |
| Q27490236 | Complement and its role in protection and pathogenesis of flavivirus infections |
| Q27650065 | Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses |
| Q36363957 | Conserved fiber-penton base interaction revealed by nearly atomic resolution cryo-electron microscopy of the structure of adenovirus provides insight into receptor interaction |
| Q45882522 | Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector |
| Q42235631 | Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells. |
| Q41847338 | Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy |
| Q24295783 | Costimulation via CD55 on human CD4+ T cells mediated by CD97 |
| Q64375251 | Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing |
| Q39848879 | Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect |
| Q64104514 | CryoEM structure of adenovirus type 3 fibre with desmoglein 2 shows an unusual mode of receptor engagement |
| Q38319400 | Crystal structure of enteric adenovirus serotype 41 short fiber head |
| Q40541096 | Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites |
| Q27663879 | Crystallographic Structure of Porcine Adenovirus Type 4 Fiber Head and Galectin Domains |
| Q36463004 | Current advances and future challenges in Adenoviral vector biology and targeting |
| Q34585554 | Current strategies and future directions for eluding adenoviral vector immunity |
| Q35659029 | Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression |
| Q39812421 | Defining the role of CD46, CD80 and CD86 in mediating adenovirus type 3 fiber interactions with host cells. |
| Q40722127 | Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs |
| Q34781681 | Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. |
| Q40296548 | Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells |
| Q40441928 | Development and assessment of human adenovirus type 11 as a gene transfer vector |
| Q27676519 | Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters |
| Q34120794 | Development of a targeted gene vector platform based on simian adenovirus serotype 24. |
| Q27010557 | Development of adenovirus capsid proteins for targeted therapeutic delivery |
| Q39229382 | Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells |
| Q37313019 | Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer |
| Q45886050 | Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob |
| Q33286806 | Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19p. |
| Q38949194 | Development of replication-deficient adenovirus malaria vaccines |
| Q36291682 | Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice |
| Q45855492 | Dilated cardiomyopathy alters the expression patterns of CAR and other adenoviral receptors in human heart |
| Q33344440 | Directed evolution generates a novel oncolytic virus for the treatment of colon cancer |
| Q40155682 | Downregulation of human CD46 by adenovirus serotype 35 vectors |
| Q38985433 | EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2. |
| Q40528538 | Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats |
| Q35857215 | Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors |
| Q37437450 | Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers |
| Q39444663 | Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells. |
| Q40548342 | Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector |
| Q36640843 | Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus |
| Q46541016 | Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors |
| Q45886064 | Efficient infection of tumor endothelial cells by a capsid-modified adenovirus |
| Q38901143 | Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vector |
| Q41006747 | Electrostatic Interactions between Complement Regulator CD46(SCR1-2) and Adenovirus Ad11/Ad21 Fiber Protein Knob. |
| Q28275236 | Emerging roles and new functions of CD46 |
| Q37976480 | Emerging roles for ubiquitin in adenovirus cell entry |
| Q92653094 | Enhanced Tropism of Species B1 Adenoviral-Based Vectors for Primary Human Airway Epithelial Cells |
| Q42255825 | Enhanced antitumor immunotherapeutic effect of B-cell-based vaccine transduced with modified adenoviral vector containing type 35 fiber structures |
| Q39662268 | Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob |
| Q46773382 | Enhancement of gene transfer to human myeloid cells by adenovirus-fiber complexes |
| Q55665997 | Enteric Species F Human Adenoviruses use Laminin-Binding Integrins as Co-Receptors for Infection of Ht-29 Cells. |
| Q36825407 | Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models |
| Q37100291 | Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy |
| Q47911679 | Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys |
| Q40250421 | Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting |
| Q34507185 | Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination |
| Q34313075 | Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. |
| Q55395331 | Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells. |
| Q38845658 | Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells |
| Q64376787 | Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants |
| Q40785963 | Fiber knob domain lacking the shaft sequence but fused to a coiled coil is a candidate subunit vaccine against egg-drop syndrome |
| Q33521271 | Fiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but promotes adenovirus host co-existence |
| Q36315434 | Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo |
| Q39889523 | Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma |
| Q39197357 | Fiber-substituted conditionally replicating adenovirus Ad5F35 induces oncolysis of human bladder cancer cells in in vitro analysis |
| Q39984572 | Flesh-eating Streptococcus pyogenes triggers the expression of receptor activator of nuclear factor-κB ligand |
| Q24623803 | Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet |
| Q26822694 | From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer |
| Q45873548 | Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism |
| Q38059008 | Gene therapy for cardiovascular disease: perspectives and potential |
| Q36378886 | Gene therapy for malignant mesothelioma: beyond the infant years |
| Q38079969 | Gene therapy for malignant mesothelioma: current prospects and challenges |
| Q36649681 | Gene therapy targeting to tumor endothelium |
| Q40545892 | Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells. |
| Q36909362 | Genetic modification of T cells for immunotherapy |
| Q39960246 | Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner |
| Q36148725 | Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy |
| Q54215469 | Glycomics and Proteomics Approaches to Investigate Early Adenovirus - Host Cell Interactions. |
| Q38713629 | Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer. |
| Q40025937 | Growth characteristics of human adenoviruses on porcine cell lines |
| Q40572143 | Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron. |
| Q33740415 | Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting |
| Q39553529 | High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral Vectors |
| Q36893512 | Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors |
| Q37729281 | Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines |
| Q92789289 | How non-enveloped viruses hijack host machineries to cause infection |
| Q35104823 | Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cells |
| Q58759854 | Human adenovirus type 17 from species D transduces endothelial cells and human CD46 is involved in cell entry |
| Q90089340 | Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptor |
| Q33262597 | Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients. |
| Q35662589 | Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis) |
| Q94496792 | Human chimeric antigen receptor macrophages for cancer immunotherapy |
| Q27648583 | Identification of CD46 Binding Sites within the Adenovirus Serotype 35 Fiber Knob |
| Q37291653 | Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer |
| Q91782856 | Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry |
| Q38299687 | Identifying functional adenovirus-host interactions using tandem mass spectrometry. |
| Q34140468 | Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promoters |
| Q34301004 | Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice |
| Q33908767 | Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity |
| Q39612726 | Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys |
| Q35085363 | Implications of the innate immune response to adenovirus and adenoviral vectors |
| Q24804662 | Improved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vector |
| Q33234748 | Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers |
| Q42326136 | Improving gene transfer in human renal carcinoma cells: Utilization of adenovirus vectors containing chimeric type 5 and type 35 fiber proteins |
| Q39946508 | In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46 |
| Q35193352 | In vitro characterization of human adenovirus type 55 in comparison with its parental adenoviruses, types 11 and 14 |
| Q45880709 | In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity |
| Q37394036 | In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors |
| Q39570773 | Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers |
| Q35261325 | Increasing the efficacy of oncolytic adenovirus vectors |
| Q37612896 | Infection kinetics of human adenovirus serotype 41 in HEK 293 cells |
| Q39502394 | Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors |
| Q33987398 | Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation |
| Q33228198 | Inhibiting complement regulators in cancer immunotherapy with bispecific mAbs |
| Q36278163 | Innate immune response to adenovirus |
| Q37718852 | Innate immunity to adenovirus |
| Q28078297 | Insights into Adenovirus Uncoating from Interactions with Integrins and Mediators of Host Immunity |
| Q37329603 | Insights into adenovirus host cell interactions from structural studies |
| Q55333613 | Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies. |
| Q47549177 | Interaction of human enterochromaffin cells with human enteric adenovirus 41 leads to serotonin release and subsequent activation of enteric glia cells |
| Q40084250 | Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells |
| Q93078512 | Intestinal HAdV Infection: Tissue Specificity, Persistence, and Implications for Antiviral Therapy |
| Q36539060 | Intracardiac injection of a capsid-modified Ad5/35 results in decreased heart toxicity when compared to standard Ad5 |
| Q39505173 | Intracellular trafficking and fate of chimeric adenovirus 5/F35 in human B lymphocytes |
| Q35914457 | Investigation of adenovirus occurrence in pediatric tumor entities. |
| Q40045829 | In Vivo Hematopoietic Stem Cell Transduction. |
| Q44406262 | Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells |
| Q38324922 | Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus |
| Q36434260 | KAP1 Is a Host Restriction Factor That Promotes Human Adenovirus E1B-55K SUMO Modification |
| Q46662084 | Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: implications for mucosal vaccines. |
| Q42716737 | Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses |
| Q40416477 | Localization of regions in CD46 that interact with adenovirus |
| Q30494333 | Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. |
| Q38017529 | Malaria vaccines: focus on adenovirus based vectors. |
| Q54948734 | Mapping of Adenovirus of serotype 3 fibre interaction to desmoglein 2 revealed a novel 'non-classical' mechanism of viral receptor engagement. |
| Q37208293 | Mechanisms of microbial traversal of the blood-brain barrier |
| Q45856180 | Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses |
| Q36387951 | Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors |
| Q37093465 | Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis |
| Q34278413 | Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured |
| Q30499616 | Microbial manipulation of receptor crosstalk in innate immunity |
| Q34533653 | Microparticle-mediated transfer of the viral receptors CAR and CD46, and the CFTR channel in a CHO cell model confers new functions to target cells |
| Q42431822 | Microtubule-mediated and microtubule-independent transport of adenovirus type 5 in HEK293 cells |
| Q27666306 | Model of the Trimeric Fiber and Its Interactions with the Pentameric Penton Base of Human Adenovirus by Cryo-electron Microscopy |
| Q34055402 | Modeling adenovirus latency in human lymphocyte cell lines |
| Q39442539 | Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11. |
| Q40192341 | Modulation of adenoviral transduction in vitro and in vivo by hyaluronan and its receptor CD44. |
| Q26864388 | Molecular basis of host specificity in human pathogenic bacteria |
| Q33353795 | Molecular engineering of viral gene delivery vehicles |
| Q34492866 | Monoclonal antibody detection of CD46 clustering beneath Neisseria gonorrhoeae microcolonies. |
| Q50092622 | Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptor. |
| Q36628042 | Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses |
| Q37619767 | Native and engineered tropism of vectors derived from a rare species D adenovirus serotype 43. |
| Q37096766 | Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo |
| Q92209901 | New Insights to Adenovirus-Directed Innate Immunity in Respiratory Epithelial Cells |
| Q37513550 | New insights on adenovirus as vaccine vectors |
| Q36331845 | New therapeutics targets in chronic viral cardiomyopathy. |
| Q45878208 | Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus |
| Q47112156 | Novel Concepts for HIV Vaccine Vector Design |
| Q37596543 | Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. |
| Q36842711 | Novel vectors for in vivo gene delivery to vascular tissue |
| Q34215308 | Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications |
| Q37687415 | Oncolytic (replication-competent) adenoviruses as anticancer agents. |
| Q33906116 | Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles |
| Q89687519 | Oncolytic adenovirus Ad11 enhances the chemotherapy effect of cisplatin on osteosarcoma cells by inhibiting autophagy |
| Q40630931 | Oncolytic viruses: the power of directed evolution |
| Q44957854 | Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities |
| Q45888470 | Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys |
| Q92730835 | Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy |
| Q52718190 | Polysialic acid is a cellular receptor for human adenovirus 52. |
| Q40518562 | Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture |
| Q45880716 | Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin |
| Q40125996 | Positive and negative regulation of adenovirus infection by CAR-like soluble protein, CLSP. |
| Q34081164 | Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28. |
| Q36744857 | Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic |
| Q42957082 | Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses |
| Q45566693 | Prevalent human coxsackie B-5 virus infects porcine islet cells primarily using the coxsackie-adenovirus receptor |
| Q45885655 | Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV. |
| Q30226988 | Production of adenovirus vectors and their use as a delivery system for influenza vaccines |
| Q38163242 | Protein engineering to target complement evasion in cancer |
| Q41765546 | Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction. |
| Q38273103 | Quantitative expression analysis of HHV-6 cell receptor CD46 on cells of human cord blood, peripheral blood and G-CSF mobilised leukapheresis cells. |
| Q38950257 | Quantum dot labelling of adenovirus allows highly sensitive single cell flow and imaging cytometry |
| Q42799957 | Quantum‐Chemical and Combined Quantum‐Chemical/Molecular‐Mechanical Studies on the Stabilization of a Twin Arginine Pair in Adenovirus Ad11 |
| Q39869397 | Receptor usage of a newly emergent adenovirus type 14. |
| Q46750116 | Recombinant Ad35 adenoviral proteins as potent modulators of human T cell activation |
| Q38769919 | Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy. |
| Q33713401 | Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver |
| Q40188439 | Rescue of chimeric adenoviral vectors to expand the serotype repertoire |
| Q64245487 | Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses |
| Q33381618 | Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. |
| Q36288468 | Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals |
| Q37347285 | Selection Pressure in the Human Adenovirus Fiber Knob Drives Cell Specificity in Epidemic Keratoconjunctivitis |
| Q37404870 | Selective transduction of mature DC in human skin and lymph nodes by CD80/CD86-targeted fiber-modified adenovirus-5/3. |
| Q37945193 | Serotype chimeric human adenoviruses for cancer gene therapy |
| Q44565772 | Shedding light on tumor targeting by adenovirus |
| Q36093470 | Silencing viruses by RNA interference |
| Q35511348 | Species D adenoviruses as oncolytics against B-cell cancers |
| Q35087653 | Species D human adenovirus type 9 exhibits better virus-spread ability for antitumor efficacy among alternative serotypes |
| Q37430989 | Specificity switching in virus-receptor complexes |
| Q27650748 | Structural Variations in Species B Adenovirus Fibers Impact CD46 Association |
| Q50091770 | Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor. |
| Q27658945 | Structure of Adenovirus Type 21 Knob in Complex with CD46 Reveals Key Differences in Receptor Contacts among Species B Adenoviruses |
| Q27650881 | Structure of the C-terminal head domain of the fowl adenovirus type 1 short fibre |
| Q27664992 | Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens |
| Q39971490 | Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver |
| Q64378494 | Synthesis, cellular localization, and quantification of penton-dodecahedron in serotype 3 adenovirus-infected cells |
| Q33249303 | Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo |
| Q24653362 | T-cell regulation by CD46 and its relevance in multiple sclerosis |
| Q36232659 | T-cell stimulation and regulation: with complements from CD46. |
| Q37322648 | TRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5 |
| Q33743670 | Targeted and restricted complement activation on acrosome-reacted spermatozoa |
| Q58753310 | Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer |
| Q42152828 | Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. |
| Q37227135 | Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody |
| Q41928339 | The Arg279Gln [corrected] substitution in the adenovirus type 11p (Ad11p) fiber knob abolishes EDTA-resistant binding to A549 and CHO-CD46 cells, converting the phenotype to that of Ad7p |
| Q39633445 | The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity |
| Q28069519 | The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein |
| Q52666285 | The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly. |
| Q36034600 | The Use of Adenovirus Dodecahedron in the Delivery of an Enzymatic Activity in the Cell |
| Q34975228 | The challenge for gene therapy: innate immune response to adenoviruses |
| Q36684556 | The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma |
| Q35950928 | The design and exogenous delivery of siRNA for post-transcriptional gene silencing. |
| Q39422790 | The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine |
| Q33908780 | The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35 |
| Q33201422 | The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3 |
| Q30834507 | The identification of an adenovirus receptor by using affinity capture and mass spectrometry. |
| Q36182171 | The influence of adenovirus fiber structure and function on vector development for gene therapy |
| Q36823688 | The influence of blood on in vivo adenovirus bio-distribution and transduction. |
| Q34077543 | The influence of delivery vectors on HIV vaccine efficacy |
| Q38908206 | The laminin receptor is a cellular attachment receptor for classical Swine Fever virus |
| Q40372177 | The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. |
| Q36023055 | The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes |
| Q35688515 | The relevance of complement to virus biology |
| Q37641568 | The role of liver sinusoidal cells in hepatocyte-directed gene transfer |
| Q36977800 | Therapeutic potential of RNA interference against cellular targets of HIV infection |
| Q36349567 | Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections |
| Q39994382 | Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors |
| Q53826123 | Transduction Properties of Adenovirus Serotype 35 Vectors After Intravenous Administration Into Nonhuman Primates. |
| Q33859402 | Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells |
| Q39278465 | Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment |
| Q45855571 | Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells. |
| Q35609035 | Transductional targeting of adenovirus vectors for gene therapy |
| Q36673736 | Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques |
| Q34781440 | Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop. |
| Q41900379 | Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D. |
| Q38614156 | Tropism-modification strategies for targeted gene delivery using adenoviral vectors |
| Q30830225 | Tumor-specific delivery of biologics by a novel T-cell line HOZOT. |
| Q35568762 | Two types of functionally distinct fiber containing structural protein complexes are produced during infection of adenovirus serotype 5 |
| Q34594959 | Unabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells |
| Q42879661 | Usage of integrin and heparan sulfate as receptors for mouse adenovirus type 1. |
| Q36246264 | Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys |
| Q34561531 | Vector platforms for gene therapy of inherited retinopathies. |
| Q35535209 | Viral Vector Effects on Exoenzyme C3 Transferase-Mediated Actin Disruption and on Outflow Facility |
| Q33894621 | Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS |
| Q92231322 | Virus recognition of glycan receptors |
| Q37646066 | Viruses as vaccine vectors for infectious diseases and cancer |
| Q45875332 | Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent |
| Q34360881 | siRNA therapeutics: big potential from small RNAs |
| Q58546247 | αvβ3 Integrin is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26 |
Search more.